PARP9 is such a protein, which promotes STAT1 activation and pro-inflammatory gene expression in IFNγ-treated macrophages15 as well as in pancreatic epithelial and cancer cells57, although PARP9 has been shown to inhibit STAT1 induction of IRF1 in prostate cancer cells58. Here, IFNG is linked to prostate carcinoma.